European Heart Journal-Quality of Care and Clinical Outcomes

European Heart Journal - Quality of Care and Clinical Outcomes is a peer-reviewed journal of the European Society of Cardiology published by Oxford University Press, founded in 2015 to cover cardiovascular outcomes research, with a 2025 Journal Impact Factor of 5.6.《欧洲心脏杂志-医疗质量与临床结局》（European Heart Journal - Quality of Care and Clinical Outcomes）为欧洲心脏病学会会刊，由（Oxford University Press）出版，2015 年创刊，刊载心血管结局研究，2025 年期刊影响因子为 5.6。

Scope

• The journal is an official peer-reviewed journal of the European Society of Cardiology with a close alliance to the European Heart Health Institute, publishing cardiovascular outcomes research.本刊为欧洲心脏病学会的官方同行评议期刊，并与欧洲心脏健康研究所保持紧密联盟关系，刊载心血管结局研究。
• Its mission is to advance innovative research in cardiovascular health and disease outcomes with implications for the organisation of cardiovascular care.刊物使命是推进对心血管健康与疾病结局具有启发意义的创新研究，服务于心血管医疗服务组织方式的改进。
• A central aim is to inform policy strategies such as national screening programmes, tobacco control, salt reduction initiatives, healthy environment promotion and equitable access to preventive care, and to drive evidence-based interventions through implementation science.其核心目标之一是为国家筛查规划、烟草控制、减盐行动、健康环境促进与预防保健公平可及等政策策略提供依据，并以实施科学推动循证干预落地。
• The journal welcomes research evaluating health policies, economic implications and cost-effectiveness, helping decision-makers translate findings into sustainable public health and clinical practice.刊物欢迎评估卫生政策、经济影响与成本效益的研究，助力决策者把研究发现转化为可持续的公共卫生与临床实践。
• Priority areas are epidemiology and population health focused on cardiometabolic risk factors in community settings, the impact of healthcare delivery on cardiovascular outcomes within health systems and communities, and cardiovascular disease prevention including clinical trials, community interventions and implementation science.优先方向包括以社区心血管代谢危险因素为重点的流行病学与人群健康、卫生系统与社区医疗服务对心血管结局的影响，以及涵盖临床试验、社区干预与实施科学的心血管病预防。
• Its readership spans researchers, clinicians, data scientists and policymakers, and accepted article types include Original Articles, Reviews, Cohort Profiles, Rapid Communications, Correspondence, Editorials and ESC Official Output.读者群覆盖研究者、临床医生、数据科学家与政策制定者；录用文章类型包括原创论文、综述、队列研究概览、快速通讯、通信、社论及学会官方文件。

History

• Oxford University Press launched the title in 2015 as the outcomes research journal of the European Society of Cardiology, with Volume 1 appearing in that year.（Oxford University Press）于 2015 年为欧洲心脏病学会创办本刊，当年即出版第 1 卷。
• From the outset the journal set out to showcase the best cardiovascular outcomes research in order to inform cardiovascular public health policy globally, and to encourage young investigators and support the growth of the outcomes research community.创刊伊始，刊物即以展示顶尖心血管结局研究、为全球心血管公共卫生政策提供依据为宗旨，并致力于扶持青年研究者、推动结局研究共同体的成长。
• Eight issues are published each year, and from January 2025 articles are available online only, the print edition having been discontinued.刊物每年出版 8 期；自 2025 年 1 月起文章转为仅在线发布，印刷版停办。
• Access is subscription based with an optional open access licence, there are no submission fees, and authors at participating institutions may publish open access under OUP Read and Publish agreements.本刊实行订阅存取，作者可选开放获取许可，不收投稿费；参与机构作者可借助（OUP）的（Read and Publish）协议免费开放获取发文。
• The 2025 Impact Factor is 5.6 and the five-year Impact Factor 5.2, ranking 44 of 237 journals in Cardiac and Cardiovascular Systems, with a 2025 Journal Citation Indicator of 1.26, a CiteScore of 10.0 and an SNIP of 1.672.2025 年影响因子为 5.6，五年影响因子 5.2，在心脏与心血管系统类 237 种期刊中排名第 44；2025 年期刊引文指标 1.26，（CiteScore）10.0，（SNIP）1.672。
• The journal received more than 200,000 downloads in 2024, is indexed in the Science Citation Index Expanded, Scopus, MEDLINE and OVID, and operates single anonymised peer review with at least two reviewers for manuscripts that pass editorial screening.2024 年本刊全文下载量超过 20 万次，被（SCIE）、Scopus、（MEDLINE）与（OVID）收录；通过编辑初审的稿件须接受至少两位审稿人的单匿名评审。

Editors

• The editor-in-chief is Massimo Piepoli of the IRCCS Policlinico San Donato in Italy, a past vice-president of the European Society of Cardiology.主编为意大利（IRCCS Policlinico San Donato）的（Massimo Piepoli），他曾任欧洲心脏病学会副主席。
• Piepoli graduated in medicine from the University of Pavia and took his PhD at Imperial College London, and he chaired the joint task force behind the 2016 ESC guidelines on cardiovascular disease prevention.（Piepoli）毕业于帕维亚大学医学院，后于伦敦帝国理工学院获博士学位，并曾主持 2016 年欧洲心脏病学会心血管疾病预防指南联合工作组。
• Below him the masthead lists five deputy editors, a senior editor, 26 associate editors, nine regional associate editors, four statistics editors, nine international editors, two social media editors and two senior consulting editors, an editorial team of nearly sixty in all.其下编辑团队包括 5 位副主编、1 位资深编辑、26 位副编辑、9 位区域副编辑、4 位统计学编辑、9 位国际编辑、2 位社交媒体编辑及 2 位资深顾问编辑，合计近 60 人。
• Associate and regional editors sit in Italy, the United Kingdom, Spain, Sweden, Switzerland, Germany, Belgium, Denmark, Norway, Cyprus, Kazakhstan, Canada, Australia, New Zealand, Poland, France, Japan, Brazil, Indonesia and the United States, among others.副编辑与区域编辑分布于意大利、英国、西班牙、瑞典、瑞士、德国、比利时、丹麦、挪威、塞浦路斯、哈萨克斯坦、加拿大、澳大利亚、新西兰、波兰、法国、日本、巴西、印度尼西亚与美国等地。
• Harry Hemingway of University College London and Panos Vardas of the European Heart Health Institute serve as senior consulting editors.（Harry Hemingway）与欧洲心脏健康研究所的（Panos Vardas）出任资深顾问编辑。